IFP Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

IFP Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-200	Closed	–	–	4223
2015 Q4	$0	Buy	+200	New	+$593	﹤0.01%	3888

Other funds holding SZYM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

IFP Advisors's SZYM Position: Q1 2016 in Review

IFP Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2016, closing a stake of 200 shares.

IFP Advisors first reported a position in SZYM in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 99 funds tracked by Wall St. Rank hold SZYM as of Q1 2016.

IFP Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
IFP Advisors sold 200 SOLAZYME INC COM STK (DE) shares in Q1 2016.
IFP Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q4 2015 and held it in 1 quarter.
IFP Advisors's SOLAZYME INC COM STK (DE) position peaked at $0 in Q4 2015.
99 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2016.

Based on IFP Advisors's 13F filing for Q1 2016, filed 2 May 2016.